Abstract
Most herpesviruses use both host and viral small non-coding RNAs (sncRNA), especially microRNA, to modulate infection. Bioinformatic analyses of NGS data obtained from Varicella Zoster virus (VZV)-infected cells predicted 24 VZVsncRNA, seven of which were confirmed to be expressed in infected fibroblasts and neurons using stem-loop quantitative reverse transcription PCR (SL-PCR). We here assayed for the expression of all 24 of the bioinformatically predicted VZVsncRNA in cells productively infected by VZV using SL-PCR. 23 of the 24 predicted sequences were detected in VZV-infected ARPE19 cells and 19 of the 24 sequences in infected human neurons generated by two methods from embryonic stem cells. We also show that blocking one of two newly-tested VZV-encoded sncRNA using locked nucleotide antagonists significantly increased viral replication. These findings suggest that further study of VZV encoded sncRNA could elucidate an additional level of regulation of the life cycle of this pathogenic human herpesvirus.
Original language | English |
---|---|
Article number | 197773 |
Journal | Virus Research |
Volume | 274 |
DOIs | |
State | Published - Dec 2019 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier B.V.
Funding
This research was supported by NIH grant R01 AI122640 and US-Israel Binational Science Foundation 2017259 to RG and PRK. RG was also supported by Israel Science Foundation grant 254/16 . PRK acknowledges additional support from core grant EY08098, and unrestricted funds from Research to Prevent Blindness, Inc and The Eye & Ear foundation of Pittsburgh. Linoy Golani was supported in part by a President’s PhD fellowship from Bar-Ilan University. Thanks to Dr. Amos Markus for many helpful discussions and critical reading of the manuscript, and to Dr. Moran Topf for technical assistance. Monoclonal antibody was developed by Drs. M. McCutcheon and S. Carroll was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa. This research was supported by NIH grant R01 AI122640 and US-Israel Binational Science Foundation2017259 to RG and PRK. RG was also supported by Israel Science Foundation grant 254/16. PRK acknowledges additional support from core grant EY08098, and unrestricted funds from Research to Prevent Blindness, Inc and The Eye & Ear foundation of Pittsburgh. Linoy Golani was supported in part by a President's PhD fellowship from Bar-Ilan University. Thanks to Dr. Amos Markus for many helpful discussions and critical reading of the manuscript, and to Dr. Moran Topf for technical assistance. Monoclonal antibody was developed by Drs. M. McCutcheon and S. Carroll was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa.
Funders | Funder number |
---|---|
Research to Prevent Blindness, Inc and The Eye & Ear foundation of Pittsburgh | |
US-Israel Binational Science | Foundation2017259 |
US-Israel Binational Science Foundation | 2017259 |
National Institutes of Health | |
National Institute of Allergy and Infectious Diseases | R01AI122640 |
Eye and Ear Foundation of Pittsburgh | |
Research to Prevent Blindness | |
University of Iowa | |
Eunice Kennedy Shriver National Institute of Child Health and Human Development | |
Bar-Ilan University | |
Israel Science Foundation | 254/16, EY08098 |
Keywords
- Human neurons
- Neurotropic virus
- Non-coding RNA
- Varicella zoster virus